← Back
Data updated: Mar 10, 2026
NAARI PTE
Dermatology
NAARI PTE is a generic drug manufacturer focused on Dermatology.
2015
Since
9
Drugs
-
Trials
16
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NORGESTIMATE AND ETHINYL ESTRADIOL 2026-01-07
Labeling
LEVONORGESTREL 2025-09-30
ESTRADIOL AND NORETHINDRONE ACETATE 2025-06-20
Labeling
ESTRADIOL AND NORETHINDRONE ACETATE 2025-06-20
Labeling
ESTRADIOL AND NORETHINDRONE ACETATE 2025-06-20
Labeling
ESTRADIOL AND NORETHINDRONE ACETATE 2025-06-20
Labeling
LEVONORGESTREL AND ETHINYL ESTRADIOL 2025-05-22
Labeling
NORGESTIMATE AND ETHINYL ESTRADIOL 2025-03-07
Labeling
DROSPIRENONE AND ETHINYL ESTRADIOL 2024-12-26
Labeling
DROSPIRENONE AND ETHINYL ESTRADIOL 2024-12-26
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (6)
Discontinued (3)
Company Info
- First Approval
- 2015-04-07
- Latest
- 2024-12-09
- Applications
- 18